Double blind, randomised controlled cross over trial comparing the antihypertensive effects of amiloride and spironolactone in black hypertensives with and without the T594M mutatio

Not Applicable

Completed

• Conditions: Hypertension; Circulatory System

• Registration Number: ISRCTN21821912
• Lead Sponsor: British Heart Foundation (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2002-03-08
• Last Update Posted: 3 April 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 0

Inclusion Criteria

1. Hypertensives of African origin
2. Subjects with the T594M polymorphism and controls with the wild-type sodium channel

Exclusion Criteria

Not provided at time of registration

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ot provided at time of registration

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration